CIR. - Compagnie Industriali Riunite Valuation

Q: What is the Fair Price of BN7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

BN7 (€0.52) is trading below our estimate of [[fair value]] (€0.88)

Is BN7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BN7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BN7 (€0.52) is trading below our estimate of fair value (€0.88)

Significantly Below Fair Value: BN7 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BN7?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for BN7. This is calculated by dividing BN7's market cap by their current preferred multiple.
What is BN7's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	€569.68m

BN7 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.7x
Enterprise Value/EBITDA	7.2x
PEG Ratio	-7.5x

Price to Earnings Ratio vs Peers

How does BN7's PE Ratio compare to its peers?

The above table shows the PE ratio for BN7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	8.3x
SFQ SAF-Holland	7.7x	7.7%	€712.7m
ZIL2 ElringKlinger	4.9x	14.3%	€263.6m
ED4 EDAG Engineering Group	8.7x	16.6%	€222.0m
NVM Novem Group	11.8x	21.5%	€280.6m
BN7 CIR. - Compagnie Industriali Riunite	35x	-4.7%	€569.7m

Price-To-Earnings vs Peers: BN7 is expensive based on its Price-To-Earnings Ratio (35x) compared to the peer average (8.3x).

Price to Earnings Ratio vs Industry

How does BN7's PE Ratio compare vs other companies in the European Auto Components Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.6%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.6%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: BN7 is expensive based on its Price-To-Earnings Ratio (35x) compared to the European Auto Components industry average (10.5x).

Price to Earnings Ratio vs Fair Ratio

What is BN7's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BN7 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	35x
Fair PE Ratio	4.4x

Price-To-Earnings vs Fair Ratio: BN7 is expensive based on its Price-To-Earnings Ratio (35x) compared to the estimated Fair Price-To-Earnings Ratio (4.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BN7 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	€0.52	€0.73 +40.5%	6.1%	€0.78	€0.69	n/a	2
Sep ’25	€0.57	€0.73 +28.9%	6.1%	€0.78	€0.69	n/a	2
Aug ’25	€0.57	€0.73 +28.5%	6.1%	€0.78	€0.69	n/a	2
Jul ’25	€0.58	€0.73 +27.4%	6.1%	€0.78	€0.69	n/a	2
Jun ’25	€0.53	€0.73 +39.7%	6.1%	€0.78	€0.69	n/a	2
May ’25	€0.54	€0.73 +35.9%	6.1%	€0.78	€0.69	n/a	2
Apr ’25	€0.52	€0.69 +34.4%	0.7%	€0.70	€0.69	n/a	2
Mar ’25	€0.49	€0.69 +41.8%	0.7%	€0.70	€0.69	n/a	2
Feb ’25	€0.40	€0.57 +42.3%	7.8%	€0.62	€0.53	n/a	2
Jan ’25	€0.40	€0.57 +44.3%	7.8%	€0.62	€0.53	n/a	2
Dec ’24	€0.41	€0.57 +41.6%	7.8%	€0.62	€0.53	n/a	2
Nov ’24	€0.35	€0.57 +62.0%	7.8%	€0.62	€0.53	n/a	2
Oct ’24	€0.38	€0.57 +51.1%	7.8%	€0.62	€0.53	€0.55	2
Sep ’24	€0.38	€0.57 +51.3%	7.8%	€0.62	€0.53	€0.57	2
Aug ’24	€0.37	€0.57 +53.5%	7.8%	€0.62	€0.53	€0.57	2
Jul ’24	€0.37	€0.57 +55.4%	7.8%	€0.62	€0.53	€0.58	2
Jun ’24	€0.34	€0.57 +67.9%	7.8%	€0.62	€0.53	€0.53	2
May ’24	€0.36	€0.57 +59.3%	7.8%	€0.62	€0.53	€0.54	2
Apr ’24	€0.37	€0.56 +51.9%	6.2%	€0.60	€0.53	€0.52	2
Mar ’24	€0.42	€0.56 +34.7%	6.2%	€0.60	€0.53	€0.49	2
Feb ’24	€0.43	€0.57 +32.8%	7.8%	€0.62	€0.53	€0.40	2
Jan ’24	€0.42	€0.57 +36.1%	7.8%	€0.62	€0.53	€0.40	2
Dec ’23	€0.40	€0.57 +43.6%	7.8%	€0.62	€0.53	€0.41	2
Nov ’23	€0.41	€0.57 +39.1%	7.8%	€0.62	€0.53	€0.35	2
Oct ’23	€0.38	€0.57 +50.7%	7.8%	€0.62	€0.53	€0.38	2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.